Current treatment paradigms and emerging therapies for NAFLD/NASH
Frontiers in Bioscience · 2021 · 26 (2) · 206-237
DOI: 10.2741/4892 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience, 2021. Verfasst von Sana Raza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India. Die Arbeit wurde bisher 286-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, DBT-Wellcome Trust India Alliance.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
- Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India, anthony.rohit@gmail.com.
Förderung
- Wellcome Trust
- DBT-Wellcome Trust India Alliance
Zitieren
APA
Raza, S., Rajak, S., Upadhyay, A., Tewari, A., & Anthony Sinha, R. (2021). Current treatment paradigms and emerging therapies for NAFLD/NASH. Frontiers in Bioscience, 26(2), 206-237. https://doi.org/10.2741/4892
Vancouver
Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatment paradigms and emerging therapies for NAFLD/NASH. Frontiers in Bioscience. 2021;26(2):206-237. doi:10.2741/4892
BibTeX
@article{Raza2021,
author = {Raza, Sana and Rajak, Sangam and Upadhyay, Aditya and Tewari, Archana and Anthony Sinha, Rohit},
title = {Current treatment paradigms and emerging therapies for NAFLD/NASH},
journal = {Frontiers in Bioscience},
year = {2021},
volume = {26},
number = {2},
pages = {206--237},
doi = {10.2741/4892}
}
EUVIMED